So they don’t explicitly mention “chronic” Lyme disease in the video, and I couldn’t find any other articles from looking up the names mentioned, but it does sound like that’s what is being talked about here.

What I would be curious about is if these patients got the antibody test. If they didn’t, that seems like a relatively easy policy fix. Bacteria can spread to other countries and go undetected, and the test isn’t that invasive compared to the peace of mind it would give patients. Same

However if they did get the test and it came back negative, then it gets more complicated. Doctors don’t want to put someone on treatment for something that can’t be detected. Every medication has side effects and you would end up harming someone without evidence of a benefit. Where it gets messy is when people go for “diagnosis” or “treatment” abroad.

I did actually find this from last October

https://www.health.gov.au/sites/default/files/2025-11/australian-government-response-to-the-senate-community-affairs-references-committee-report-access-to-diagnosis-and-treatment-for-tick-borne-diseases.pdf

 Overview

The Australian Government appreciates the opportunity to respond to the Senate
Community Affairs References Committee list of recommendations on the Access to
diagnosis and treatment for people in Australia with tick-borne diseases. The Government
thanks the Committee and the various stakeholders for their valuable and thoughtful input
to the Inquiry.
The Government acknowledges the concerns of patients who are facing issues accessing
diagnosis and treatment with tick-borne illnesses. In early 2013, the Department of Health,
Disability and Ageing began engaging with patients, medical practitioners, and advocacy
groups to discuss concerns about Lyme disease. In 2016, the department engaged and
addressed the Senate Inquiry recommendations into Growing evidence of an emerging tick-
borne disease that causes a Lyme-like illness (2016 Inquiry) through a range of measures
such as public education materials, research and guidance for medical practitioners. As a
result, the department has gained a deeper appreciation and growing concern for those
Australians experiencing issues relating to tick-borne diseases.
This response addresses the specific recommendations raised in the current Senate
Committee's Report. The Government remains open-minded about the cause of the various
complexes which manifest as a range of chronic debilitating symptoms. The best outcome
for patients and health practitioners is to not draw conclusions based on poor levels of
evidence, but to consider each patient thoroughly in a multidisciplinary medical approach
that makes the best use of clinical expertise and available diagnostic skills and technology.
The Government remains engaged with the patient and medical community to continue to
find, share and understand the evidence associated with tick-borne diseases. The
Government hopes its continued work with clinical medicine and research communities will
result in answers and relief for patients and their families